Substance P acting via the neurokinin-1 receptor regulates adverse myocardial remodeling in a rat model of hypertension
Authors:
- 1 October 2013
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 168 (5) , 4643-4651
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Substance P enhances collagen remodeling and MMP‐3 expression by human tenocytesJournal of Orthopaedic Research, 2012
- Pressure overload-dependent membrane type 1-matrix metalloproteinase induction: relationship to LV remodeling and fibrosisAmerican Journal of Physiology-Heart and Circulatory Physiology, 2012
- Progressive induction of left ventricular pressure overload in a large animal model elicits myocardial remodeling and a unique matrix signatureThe Journal of Thoracic and Cardiovascular Surgery, 2012
- Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cellsCardiovascular Research, 2011
- Targeted Deletion of Matrix Metalloproteinase 2 Ameliorates Myocardial Remodeling in Mice With Chronic Pressure OverloadHypertension, 2006
- TRPV1 Gene Knockout Impairs Postischemic Recovery in Isolated Perfused Heart in MiceCirculation, 2005
- Chronic ETAReceptor Blockade Attenuates Cardiac Hypertrophy Independently of Blood Pressure Effects in Renovascular Hypertensive RatsHypertension, 1999
- Magnesium-deficiency-enhanced Post-ischemic Myocardial Injury is Reduced by Substance P Receptor BlockadeJournal of Molecular and Cellular Cardiology, 1997
- Increased plasma level of substance P in patients with severe congestive heart failure treated with ACE inhibitorsJournal of Internal Medicine, 1991
- Ultrastructural localisation of substance P and choline acetyltransferase in endothelial cells of rat coronary artery and release of substance P and acetylcholine during hypoxiaCellular and Molecular Life Sciences, 1989